• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压作为心力衰竭的一个风险因素。

Hypertension as a risk factor for heart failure.

作者信息

Kannan Arun, Janardhanan Rajesh

机构信息

Section of Cardiology, Sarver Heart Center, University of Arizona College of Medicine, Tucson, AZ, USA,

出版信息

Curr Hypertens Rep. 2014 Jul;16(7):447. doi: 10.1007/s11906-014-0447-7.

DOI:10.1007/s11906-014-0447-7
PMID:24792121
Abstract

Hypertension remains a significant risk factor for development of congestive heart failure CHF), with various mechanisms contributing to both systolic and diastolic dysfunction. The pathogenesis of myocardial changes includes structural remodeling, left ventricular hypertrophy, and fibrosis. Activation of the sympathetic nervous system and renin-angiotensin system is a key contributing factor of hypertension, and thus interventions that antagonize these systems promote regression of hypertrophy and heart failure. Control of blood pressure is of paramount importance in improving the prognosis of patients with heart failure.

摘要

高血压仍然是发生充血性心力衰竭(CHF)的一个重要危险因素,多种机制导致收缩和舒张功能障碍。心肌变化的发病机制包括结构重塑、左心室肥厚和纤维化。交感神经系统和肾素-血管紧张素系统的激活是高血压的一个关键促成因素,因此拮抗这些系统的干预措施可促进肥厚和心力衰竭的消退。控制血压对于改善心力衰竭患者的预后至关重要。

相似文献

1
Hypertension as a risk factor for heart failure.高血压作为心力衰竭的一个风险因素。
Curr Hypertens Rep. 2014 Jul;16(7):447. doi: 10.1007/s11906-014-0447-7.
2
[Arterial hypertension and systolic left ventricular dysfunction: therapeutic approach].[动脉高血压与左心室收缩功能障碍:治疗方法]
Rev Esp Cardiol. 1999;52 Suppl 3:34-8.
3
The role of hypertension in the pathogenesis of heart failure. A clinical mechanistic overview.高血压在心力衰竭发病机制中的作用。临床机制概述。
Arch Intern Med. 1996 Sep 9;156(16):1789-96.
4
From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.从左心室肥厚到充血性心力衰竭:高血压性心脏病的管理
Prog Cardiovasc Dis. 2006 Mar-Apr;48(5):326-41. doi: 10.1016/j.pcad.2006.02.001.
5
The cardiac structure-function relationship and the renin-angiotensin-aldosterone system in hypertension and heart failure.高血压和心力衰竭中的心脏结构-功能关系及肾素-血管紧张素-醛固酮系统
Curr Opin Cardiol. 1994 Jul;9 Suppl 1:S2-10; discussion S10-1. doi: 10.1097/00001573-199407000-00002.
6
The progression from hypertension to congestive heart failure.从高血压发展到充血性心力衰竭。
JAMA. 1996;275(20):1557-62.
7
Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.β受体阻滞剂可改善舒张性心力衰竭高血压大鼠的生存率、左心室功能和心肌重塑。
Am J Hypertens. 2004 Dec;17(12 Pt 1):1112-9. doi: 10.1016/j.amjhyper.2004.07.007.
8
Mechanisms of development of heart failure in the hypertensive patient.高血压患者心力衰竭的发病机制。
Cardiology. 1999;92 Suppl 1:3-6; discussion 7-9, 20-1. doi: 10.1159/000047287.
9
Congestive heart failure due to hypertensive ventricular diastolic dysfunction.高血压性心室舒张功能障碍所致充血性心力衰竭
Am J Cardiol. 1995 Nov 2;76(13):43D-47D. doi: 10.1016/s0002-9149(99)80491-3.
10
Effects of omapatrilat on cardiac nerve sprouting and structural remodeling in experimental congestive heart failure.奥帕曲拉对实验性充血性心力衰竭中心脏神经芽生和结构重塑的影响。
Heart Rhythm. 2005 Sep;2(9):984-90. doi: 10.1016/j.hrthm.2005.05.016.

引用本文的文献

1
Clinical and economic impact of cost-intensive vs non-cost-intensive antihypertensive therapies: a retrospective study using real-world data from Japan.成本密集型与非成本密集型抗高血压治疗的临床和经济影响:一项使用日本真实世界数据的回顾性研究。
BMJ Open. 2025 Jul 16;15(7):e097305. doi: 10.1136/bmjopen-2024-097305.
2
The effect of Shirodhara on essential hypertension: Systematic review and meta-analysis.希罗达拉疗法对原发性高血压的影响:系统评价与荟萃分析。
J Educ Health Promot. 2025 Jan 31;14:28. doi: 10.4103/jehp.jehp_464_24. eCollection 2025.
3
Association between pathological scar and hypertension: A two-sample Mendelian randomization study.

本文引用的文献

1
Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial.肾去交感神经术治疗药物抵抗性高血压:Symplicity HTN-2 随机、对照试验的一年结果。
Circulation. 2012 Dec 18;126(25):2976-82. doi: 10.1161/CIRCULATIONAHA.112.130880.
2
Heart disease and stroke statistics--2013 update: a report from the American Heart Association.《2013年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2013 Jan 1;127(1):e6-e245. doi: 10.1161/CIR.0b013e31828124ad. Epub 2012 Dec 12.
3
Angiotensin receptor blockers for heart failure.
病理性瘢痕与高血压之间的关联:一项两样本孟德尔随机化研究。
Medicine (Baltimore). 2024 Dec 27;103(52):e40977. doi: 10.1097/MD.0000000000040977.
4
Postoperative outcomes linked to congestive heart failure in arthroscopic rotator cuff repair.关节镜下肩袖修复术中与充血性心力衰竭相关的术后结果
Eur J Orthop Surg Traumatol. 2025 Feb 13;35(1):71. doi: 10.1007/s00590-025-04192-w.
5
Fluid volume status detection model for patients with heart failure based on machine learning methods.基于机器学习方法的心力衰竭患者液体容量状态检测模型
Heliyon. 2024 Dec 11;11(1):e41127. doi: 10.1016/j.heliyon.2024.e41127. eCollection 2025 Jan 15.
6
Exploring in vivo and in vitro models for heart failure with biomarker insights: a review.基于生物标志物洞察探索心力衰竭的体内和体外模型:综述
Egypt Heart J. 2024 Oct 21;76(1):141. doi: 10.1186/s43044-024-00568-1.
7
Experience and the nutritional relevance of protein-enriched ice cream in patients with heart failure - A pilot study.富含蛋白质的冰淇淋在心力衰竭患者中的经验及营养相关性——一项初步研究。
Heliyon. 2024 Jun 25;10(13):e33661. doi: 10.1016/j.heliyon.2024.e33661. eCollection 2024 Jul 15.
8
Association between ambient particulate matter levels and hypertension: results from the Korean Genome and Epidemiology Study.环境颗粒物水平与高血压之间的关联:韩国基因组与流行病学研究结果
Ann Occup Environ Med. 2023 Dec 4;35:e51. doi: 10.35371/aoem.2023.35.e51. eCollection 2023.
9
A time-series minimally invasive transverse aortic constriction mouse model for pressure overload-induced cardiac remodeling and heart failure.一种用于压力超负荷诱导的心脏重塑和心力衰竭的时间序列微创性横断主动脉缩窄小鼠模型。
Front Cardiovasc Med. 2023 Feb 20;10:1110032. doi: 10.3389/fcvm.2023.1110032. eCollection 2023.
10
A Novel Nomogram Integrated with Systemic Inflammation Markers and Traditional Prognostic Factors for Adverse Events' Prediction in Patients with Chronic Heart Failure in the Southwest of China.一种结合全身炎症标志物和传统预后因素的新型列线图,用于预测中国西南部慢性心力衰竭患者的不良事件
J Inflamm Res. 2022 Dec 20;15:6785-6800. doi: 10.2147/JIR.S366903. eCollection 2022.
用于治疗心力衰竭的血管紧张素受体阻滞剂
Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD003040. doi: 10.1002/14651858.CD003040.pub2.
4
The human sympathetic nervous system: its relevance in hypertension and heart failure.人体交感神经系统:在高血压和心力衰竭中的相关性。
Eur Heart J. 2012 May;33(9):1058-66. doi: 10.1093/eurheartj/ehs041. Epub 2012 Apr 16.
5
Progression from normal to reduced left ventricular ejection fraction in patients with concentric left ventricular hypertrophy after long-term follow-up.长期随访后,向心性左心室肥厚患者的左心室射血分数从正常逐渐降低。
Am J Cardiol. 2011 Oct 1;108(7):997-1001. doi: 10.1016/j.amjcard.2011.05.037. Epub 2011 Jul 27.
6
Progression from concentric left ventricular hypertrophy and normal ejection fraction to left ventricular dysfunction.从向心性左心室肥厚伴正常射血分数进展为左心功能障碍。
Am J Cardiol. 2011 Oct 1;108(7):992-6. doi: 10.1016/j.amjcard.2011.05.038. Epub 2011 Jul 23.
7
An updated concept for left ventricular hypertrophy risk in hypertension.高血压患者左心室肥厚风险的最新概念。
Ochsner J. 2009 Winter;9(4):181-90.
8
Eplerenone in patients with systolic heart failure and mild symptoms.依普利酮治疗有收缩性心力衰竭和轻度症状的患者。
N Engl J Med. 2011 Jan 6;364(1):11-21. doi: 10.1056/NEJMoa1009492. Epub 2010 Nov 14.
9
The hypertensive heart. An integrated understanding informed by imaging.高血压性心脏病。影像学提供的综合认识。
J Am Coll Cardiol. 2010 Jan 12;55(2):91-6. doi: 10.1016/j.jacc.2009.07.059.
10
Therapeutic approaches to diastolic dysfunction.舒张功能障碍的治疗方法。
Curr Hypertens Rep. 2009 Aug;11(4):283-91. doi: 10.1007/s11906-009-0048-z.